EZETIMIBE ROSUV Spirig HC cpr pell 10/5mg 100 pce

7680680690062 CH-68069 C10BA06 07.12.0.

Reimbursement limitations:

EZET ROS SPI

EZETIMIB-ROSUVASTATIN SPIRIG HC est indiqué comme traitement substitutif chez le patient adulte qui reçoit déjà …

EZETIMIBE ROSUV Spirig HC cpr pell 10/5mg 100 pce
EZETIMIBE ROSUV Spirig HC cpr pell 10/5mg 100 pce
EZETIMIBE ROSUV Spirig HC cpr pell 10/5mg 100 pce
1 / 3
google

Details

Product number
6806904
CPT
-
Packaging group
100
Unit
Tablette(n)
Composition
ezetimibum 10 mg, rosuvastatinum 5 mg ut rosuvastatinum calcicum, lactosum monohydricum 200.5 mg, carmellosum natricum conexum, povidonum K 29-32, natrii laurilsulfas, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 4000, E 172 (flavum), talcum, E 172 (rubrum), pro compresso obducto corresp. natrium 3 mg.

Articles (1)

Ezetimib Rosuvastatin Spirig HC 10 mg / 5 mg, Filmtabletten
Filmtabletten
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/07/2024
Patient information leaflet
Français
24/07/2024
Patient information leaflet
Italien
24/07/2024
Professional SmPC
Allemand
24/07/2024
Professional SmPC
Français
24/07/2024

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
200.5 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
3.0 MG Substance HBESI

Reimbursement information

Public price
CHF 93.50
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2025

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
68069
Drug name
Ezetimib Rosuvastatin Spirig HC, Filmtabletten
Galenic form
FILM
ATC Code
C10BA06
Authorization status
Z
Dispensation category
B
First authorization
25/06/2021
Authorization expiration date
31/12/9999
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration

Packaging details

Description (FR)
EZETIMIBE ROSUV Spirig HC cpr pell 10/5mg 100 pce
Description (DE)
EZETIMIB ROSUV Spirig HC Filmtabl 10/5mg 100 Stk
Market launch
11/07/2024
Narcotic (BTM)
No

Other packaging sizes

EZETIMIBE ROSUV Spirig HC cpr pell 10/10mg 30 pce
30 TABL
View
EZETIMIBE ROSUV Spirig HC cpr pell 10/10mg 100 pce
100 TABL
View
EZETIMIBE ROSUV Spirig HC cpr pell 10/20mg 30 pce
30 TABL
View
EZETIMIBE ROSUV Spirig HC cpr pell 10/20mg 100 pce
100 TABL
View
EZETIMIBE ROSUV Spirig HC cpr pell 10/5mg 30 pce
30 TABL
View